Search Tag: Blood Cancer
2023 07 Dec
Presented at the American Society of Hematology (ASH) 65th annual meeting AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythemia vera (PV) 1 These...Read more